Päivi M. Paldánius Australian Diabetes Society and the Australian Diabetes Educators Association Annual Scientific Meeting 2014

Abstracts this author is presenting:

• Expectations and aspirations of patients and physicians at the diagnosis of type 2 diabetes — ADS Clinical Poster Viewing & Discussion
• Real world effectiveness of vildagliptin vs other OADs as add-on to sulphonylureas in T2DM patients not receiving metformin: post-hoc analysis from the EDGE study — ADS Clinical Poster Viewing & Discussion
• Vildagliptin Efficacy in combination with metfoRmIn For earlY treatment of type 2 diabetes mellitus (VERIFY) — ADS Clinical Poster Viewing & Discussion
• Glycaemic control in elderly people with T2DM in clinical trial, observational and individualised care settings — ADS Clinical Poster Viewing & Discussion
• Real-life effectiveness of OADs as add-on therapy after monotherapy failure in patients with substantial hyperglycaemia (HbA1c ≥10.0%): a post-hoc analysis of the EDGE study — ADS Clinical Poster Viewing & Discussion
• Inter-regional differences in the real-world achievement of glycaemic control with dual OAD combinations for the treatment of T2DM — ADS Clinical Poster Viewing & Discussion
• Real-life observation of the effectiveness and tolerability of vildagliptin in Hispanic Native American T2DM patients — ADS Clinical Poster Viewing & Discussion